Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The IND Process: Innovation and challenges
View through CrossRef
The Investigational New Drug (IND) process
serves as a crucial framework for the development
and approval of new pharmaceuticals, ensuring
they meet essential safety and efficacy standards
before being administered to human subjects. This
review article comprehensively examines the IND
process, beginning with its foundational role in
transitioning drug candidates from preclinical
research to clinical trials. The significance of
regulatory agencies, particularly the U.S. Food and
Drug Administration (FDA) and the European
Medicines Agency (EMA), in overseeing the IND
submission and approval process is highlighted,
emphasizing their responsibility to safeguard public
health.The article provides an in-depth analysis of
the various components involved in an IND
application, including preclinical study results, trial
protocols, and safety data. It also explores the
different phases of clinical trials—Phase 1 to Phase
3—illustrating how these phases collectively
contribute to understanding a drug's safety, optimal
dosage, and efficacy. Furthermore, the challenges
faced in the IND process, such as regulatory delays,
safety concerns, and compliance issues, are
discussed, alongside recent innovations that are
reshaping drug development, including
advancements in technology and regulatory
practices
Title: The IND Process: Innovation and challenges
Description:
The Investigational New Drug (IND) process
serves as a crucial framework for the development
and approval of new pharmaceuticals, ensuring
they meet essential safety and efficacy standards
before being administered to human subjects.
This
review article comprehensively examines the IND
process, beginning with its foundational role in
transitioning drug candidates from preclinical
research to clinical trials.
The significance of
regulatory agencies, particularly the U.
S.
Food and
Drug Administration (FDA) and the European
Medicines Agency (EMA), in overseeing the IND
submission and approval process is highlighted,
emphasizing their responsibility to safeguard public
health.
The article provides an in-depth analysis of
the various components involved in an IND
application, including preclinical study results, trial
protocols, and safety data.
It also explores the
different phases of clinical trials—Phase 1 to Phase
3—illustrating how these phases collectively
contribute to understanding a drug's safety, optimal
dosage, and efficacy.
Furthermore, the challenges
faced in the IND process, such as regulatory delays,
safety concerns, and compliance issues, are
discussed, alongside recent innovations that are
reshaping drug development, including
advancements in technology and regulatory
practices.
Related Results
Social innovation : understanding selected Durban-based interior designers' perceptions of socially responsible interior design
Social innovation : understanding selected Durban-based interior designers' perceptions of socially responsible interior design
In a world with pressing social issues that require the collaboration of multiple stakeholders to solve them, this research sought to find out through the views of interior design ...
Land use evolution over time using public data and a new environmental indicator. Application to the Valencia region (Spain)
Land use evolution over time using public data and a new environmental indicator. Application to the Valencia region (Spain)
<p>In this work a new environmental indicator for the analysis of land use change over time (ENV-IND) is presented. The ENV-IND indicator has been defined and assigne...
Framing the Innovation Mindset
Framing the Innovation Mindset
Aim/Purpose: To build the skills of innovation, we must first establish a framework for the belief system that surrounds effective innovation practice. In building any belief syst...
Framing the Innovation Mindset
Framing the Innovation Mindset
Aim/Purpose: To build the skills of innovation, we must first establish a framework for the belief system that surrounds effective innovation practice. In building any belief syst...
TIPS FOR A SUCCESSFUL APPLICATION OF INNOVATION IN A BUSINESS
TIPS FOR A SUCCESSFUL APPLICATION OF INNOVATION IN A BUSINESS
For a company, the innovation process can be very costly in terms of time and resources if not planned properly. Therefore, companies must take the right steps for innovation and l...
Innovation in family firms: The Brittelstand
Innovation in family firms: The Brittelstand
PurposeThe Brittelstand are innovative, family-owned firms that offer national and international opportunities in the United Kingdom (UK). These fast-growing businesses are custome...
On the IND-CCA1 Security of FHE Schemes
On the IND-CCA1 Security of FHE Schemes
Fully homomorphic encryption (FHE) is a powerful tool in cryptography that allows one to perform arbitrary computations on encrypted material without having to decrypt it first. Th...
Intensity and Prevalence of Ectoparasites in Carp in Cirata Reservoir KJA, Cianjur Regency, West Java
Intensity and Prevalence of Ectoparasites in Carp in Cirata Reservoir KJA, Cianjur Regency, West Java
One of the problems that arise in fish farming is the occurrence of disease attacks that can cause losses to farmers. Parasites that are classified as ectoparasites themselves usua...